Bacterial vaginosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Effective measure for the secondary prevention of infective conjunctivitis include maintaining vaginal pH at 4.5, bacteriotherapy, avoid douching and change in the method of contraception.^[1]^[2]^[3]^[4]

Secondary prevention

Effective measure for the secondary prevention of infective conjunctivitis include:^[1]^[2]^[3]^[4]

Maintaining vaginal pH at 4.5
- Use intravaginal lactate gel
- Bacteriotherapy
  - Intravaginal and oral administration of lactobacilli
Stop douching
Changing the method of contraception

References

↑ ^1.0 ^1.1 Wilson J (2004). “Managing recurrent bacterial vaginosis”. Sex Transm Infect. 80 (1): 8–11. PMC 1758381. PMID 14755028.
↑ ^2.0 ^2.1 Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM; et al. (2013). “Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use”. Clin Infect Dis. 56 (6): 777–86. doi:10.1093/cid/cis1030. PMID 23243173.
↑ ^3.0 ^3.1 Reid G, Beuerman D, Heinemann C, Bruce AW (2001). “Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora”. FEMS Immunol Med Microbiol. 32 (1): 37–41. PMID 11750220.
↑ ^4.0 ^4.1 Andersch B, Lindell D, Dahlén I, Brandberg A (1990). “Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel”. Gynecol Obstet Invest. 30 (2): 114–9. PMID 2245947.

Template:WH Template:WS

[pmid14755028-1] 1.0 ^1.1 Wilson J (2004). “Managing recurrent bacterial vaginosis”. Sex Transm Infect. 80 (1): 8–11. PMC 1758381. PMID 14755028.

[pmid23243173-2] 2.0 ^2.1 Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM; et al. (2013). “Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use”. Clin Infect Dis. 56 (6): 777–86. doi:10.1093/cid/cis1030. PMID 23243173.

[pmid11750220-3] 3.0 ^3.1 Reid G, Beuerman D, Heinemann C, Bruce AW (2001). “Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora”. FEMS Immunol Med Microbiol. 32 (1): 37–41. PMID 11750220.

[pmid2245947-4] 4.0 ^4.1 Andersch B, Lindell D, Dahlén I, Brandberg A (1990). “Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel”. Gynecol Obstet Invest. 30 (2): 114–9. PMID 2245947.

[1]

[2]

[3]

[4]